TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 2 | -3 | -11 | 4 | 27 | 24 | 7 |
| P | %wins | 67 | 33 | 33 | 33 | 33 | 67 | 44 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/20/14 21:19 | 11/20/14 | APDN | Applied Dna Sciences Inc | DE | BizSv | BizSv | Miscellaneous Business Servic | Hayward James A | NY | DOT | CB,CEO,P | P.d | 249 | 3.24 | 0 | 77 | 4 | 1,919 | D | -75 | -62 | -59 | -55 | -50 | -55 | -54 | -30 | -4 | -14 | 0 | 45 | -5 | 63 |
9/6/06 20:13 | 11/4/05 | APDN | Applied Dna Sciences Inc | NV | Health | BioPrd | Biological Products, (No Diag | Hayward James A | NY | DO | CEO | P.dm | 36 | 0.1401 | 0 | 259 | 999% | 259 | D | -86 | -88 | -50 | -55 | -10 | -10 | -18 | -10 | 10 | 33 | -11 | -11 | 122 | 22 |
7/12/06 19:35 | 7/11/06 | APDN | Applied Dna Sciences Inc | NV | Health | BioPrd | Biological Products, (No Diag | Hayward James A | NY | DO | CEO | P.d | 30 | 0.1300 | 0 | 234 | 938 | 259 | D | -80 | -79 | -48 | -36 | -30 | -18 | 0 | 0 | 0 | -29 | -21 | -21 | -36 | -14 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |